<DOC>
	<DOCNO>NCT02492802</DOCNO>
	<brief_summary>Posaconazole plasma concentration inflammatory marker determine sample available routine analysis .</brief_summary>
	<brief_title>Effect Inflammation Pharmacokinetics Posaconazole</brief_title>
	<detailed_description>A prospective observational study perform University Medical Center Groningen , Netherlands use longitudinal data collection . The design study patient start posaconazole treatment evaluate . After informed consent obtain medical data collect medical chart . Posaconazole plasma concentration ( trough level ) inflammatory marker ( e.g . C-reactive protein ) determine sample available routine analysis ( often daily ) . This result detail data set capturing day day variation inflammation drug concentration .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Posaconazole</mesh_term>
	<criteria>&gt; 18 yr receive posaconazole Written inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>